XpresSpa Group Supports Airlines to Meet Dutch Travel Restrictions; XpresCheck to Pilot Rapid COVID-19 Antigen Tests for Tran...
January 28 2021 - 08:30AM
XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”)
announces working with major airlines carriers out of John F.
Kennedy International’s Terminal 4, Newark Liberty International
Airport and Boston’s Logan International Airport to the
Netherlands. The Netherlands’ new COVID-19 testing policy for
incoming international passengers requires a negative COVID-19 PCR
test within 72 hours before departure as well as a negative
COVID-19 rapid test four hours before departure. This has become
the strictest travel requirement globally.
XpresCheck is collaborating with United
Airlines, Delta Air Lines and KLM Royal Dutch Airlines to meet the
new rapid 4-hour test requirements at select airports. In addition
to its rapid molecular ABBOTT ID NOW COVID-19 tests, XpresCheck is
going to pilot, at JFK Terminal 4, the implementation of a rapid
antigen test next week, administering BD’s rapid SARS-CoV-2 test
for the BD Veritor™ Plus System.
“XpresCheck is committed to taking a leadership
position in airport COVID-19 testing to keep travelers on-track and
safe,” said Doug Satzman, CEO of XpresSpa. “Whether working with
these major airlines, supporting safe transatlantic flights or
expanding testing capabilities, XpresCheck continuously works to
meet the changing domestic and global health and travel
restrictions to ensure the safest method of flying for all
passengers.”
Satzman further states, “We are also going to
pilot a new rapid testing extension program, operated by the gate
in JFK Terminal 4, to help connecting passengers traveling to
Amsterdam to meet this new restriction.”
For more information about XpresSpa please visit
https://xprescheck.com.
About XpresSpa Group, Inc.
XpresSpa Group, Inc. (Nasdaq: XSPA) is a
leading global health and wellness holding company. XpresSpa
Group’s core asset, XpresSpa, is a leading airport retailer of
spa services and related health and wellness products, with 45
locations in 23 airports globally. Through its XpresTest,
Inc. subsidiary, the Company provides COVID-19 screening and
testing under the XpresCheck™ brand at seven locations in six
airports: Denver International Airport, JFK International
Airport, Logan International Airport (2), Newark
Liberty International Airport, Phoenix Sky Harbor
International Airport, and Salt Lake City International Airport. To
learn more about XpresSpa Group,
visit: www.XpresSpaGroup.com.
Twitter: @xprescheck and
Instagram: @realxprescheck
Forward-Looking Statements
Forward-Looking Statements This press release
may contain "forward-looking" statements within the meaning of
Section 27A of the Securities Act of 1933, and Section 21E of the
Securities Exchange Act of 1934. These include statements preceded
by, followed by or that otherwise include the words "believes,"
"expects," "anticipates," "estimates," "projects," "intends,"
"should," "seeks," "future," "continue," or the negative of such
terms, or other comparable terminology. In particular, these
statements include, without limitation, statements about our
expectations relating to our new XpresCheck™ concept, being able to
expand testing to other communicable diseases as well as administer
vaccinations for the seasonal flu, our positioning to be part of
the national rollout of various COVID-19 vaccinations as they
become available, the degree to which our public testing model
assists passengers meet testing requirements in select states and
countries, our ability to identify and gain access to the latest
and best COVID-19 testing methodologies and equipment, and our
ability further expand our initial sites and our overall ability to
manage the regulatory challenges associated with this business
line. Forward-looking statements relating to expectations about
future results or events are based upon information available
to XpresSpa Group as of today's date and are not
guarantees of the future performance of the company, and actual
results may vary materially from the results and expectations
discussed. Additional information concerning these and other risks
is contained in XpresSpa Group’s most recently filed Annual Report
on Form 10-K, Quarterly Report on Form 10-Q, recent Current Reports
on Form 8-K and other Securities and Exchange
Commission filings. All subsequent written and oral
forward-looking statements concerning XpresSpa Group, or other
matters and attributable to XpresSpa Group or any person
acting on its behalf are expressly qualified in their entirety by
the cautionary statements above. XpresSpa Group does not
undertake any obligation to publicly update any of these
forward-looking statements to reflect events or circumstances that
may arise after the date hereof.
Media - XpresSpaJulie
Ferguson Julie@jfprmedia.com(312) 385-0098
Investor Relations -
XpresSpaICRRaphael Gross(203) 682-8253
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Feb 2024 to Mar 2024
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Mar 2023 to Mar 2024